Aurigene Oncology Limited
Records under this name other than the patents Aurigene Oncology Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 46 patents it holds.
Back to Aurigene Oncology Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,428,379 | Acylsulfonamide KAT6A Inhibitors now held by Olema Pharmaceuticals, Inc. In force · High confidence | In force | High confidence | |
| US 10,077,259 | Bicyclic Heterocyclic Derivatives as Bromodomain Inhibitors Lapsed on the fee record Ended Sep 18, 2026 · High confidence | Lapsed on the fee record | Ended Sep 18, 2026 | High confidence |
| US 11,332,460 | Process for the Preparation of a Sulfonamide Structured Kinase Inhibitor Lapsed on the fee record Ended May 17, 2026 · High confidence | Lapsed on the fee record | Ended May 17, 2026 | High confidence |
| US 11,311,517 | Combination of Small Molecule CD-47 Inhibitors with Other Anti-Cancer Agents Lapsed on the fee record Ended Apr 26, 2026 · High confidence | Lapsed on the fee record | Ended Apr 26, 2026 | High confidence |
| US 11,186,576 | Pyrazolo[1,5-a][1,3,5]triazine and Pyrazolo[1,5-a]pyrimidine Derivatives as CDK Inhibitors Lapsed on the fee record Ended Nov 30, 2025 · High confidence | Lapsed on the fee record | Ended Nov 30, 2025 | High confidence |
| US 10,870,637 | Process for the Preparation of a Sulfonamide Structured Kinase Inhibitor Lapsed on the fee record Ended Dec 22, 2024 · High confidence | Lapsed on the fee record | Ended Dec 22, 2024 | High confidence |
| US 12,005,045 | Method of Modulating Tigit and PD-1 Signalling Pathways Using 1,2,4-Oxadiazole Compounds Term ended Term ended May 25, 2022 · High confidence | Term ended | Term ended May 25, 2022 | High confidence |
| 14/478,759 | 1,2,4-Oxadiazole Derivatives as Immunomodulators Abandoned Abandoned Oct 25, 2016 | Abandoned | Abandoned Oct 25, 2016 | |
| 16/343,681 | Dual Inhibitors of Vista and PD-1 Pathways Abandoned Abandoned Apr 3, 2025 | Abandoned | Abandoned Apr 3, 2025 | |
| 17/045,916 | Method of Modulating Tigit and PD-1 Signalling Pathways Using 1,2,4-Oxadiazole Compounds Abandoned Abandoned Jul 22, 2026 | Abandoned | Abandoned Jul 22, 2026 |